journal article·2022-03-14

Silk Fibroin Microparticle Scaffold for Use in Bone Void Filling: Safety and Efficacy Studies

Rucha Deshpande, Swati Shukla, Amod Kale, Narendra Deshmukh, Anuya Nisal, Premnath Venugopalan

Publisher page

Abstract

Silk fibroin (SF) is a natural biocompatible protein polymer extracted from cocoons of silkworm Bombyx mori. SF can be processed into a variety of different forms and shapes that can be used as scaffolds to support bone regeneration. Three-dimensional (3D) SF scaffolds have shown promise in bone-void-filling applications. In in vitro studies, it has been demonstrated that a microparticle-based SF (M-RSF) scaffold promotes the differentiation of stem cells into an osteoblastic lineage. The expression of differentiation markers was also significantly higher for M-RSF scaffolds as compared to other SF scaffolds and commercial ceramic scaffolds. In this work, we have evaluated the in vitro and in vivo biocompatibility of M-RSF scaffolds as per the ISO 10993 guidelines in a Good Laboratory Practice (GLP)-certified facility. The cytotoxicity, immunogenicity, genotoxicity, systemic toxicity, and implantation studies confirmed that the M-RSF scaffold is biocompatible. Further, the performance of the M-RSF scaffold to support bone formation was evaluated in in vivo bone implantation studies in a rabbit model. Calcium sulfate (CaSO4) scaffolds were chosen as reference material for this study as they are one of the preferred materials for bone-void-filling applications. M-RSF scaffold implantation sites showed a higher number of osteoblast and osteoclast cells as compared to CaSO4 implantation sites indicating active bone remodeling. The number density of osteocytes was double for M-RSF scaffold implantation sites, and these M-RSF scaffold implantation sites were characterized by enhanced collagen deposition, pointing toward a finer quality of the new bone formed. Moreover, the M-RSF scaffold implantation sites had a negligible incidence of secondary fractures as compared to the CaSO4 implantation sites (∼50% sites with secondary fracture), implying a reduction in postsurgical complications. Thus, the study demonstrates that the M-RSF scaffold is nontoxic for bone-void-filling applications and facilitates superior healing of fracture defects as compared to commercial calcium-based bone void fillers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Serigen Mediproducts Pvt Ltd., Plot no. 9, Electronic Co-op Estate, Satara Road, Parvati Paytha, Pune 411009, India

Intox Private Limited, Pune, 375, Urawade, Tal. Mulshi, Pune 412115, India

Polymer Science and Engineering Dept., CSIR-National Chemical Laboratory, Homi Bhabha Road, Pashan, Pune 411008, India

Funding

Department of Biotechnology , Ministry of Science and Technology

References (41)

Show source-provided references
1. 10.1155/2013/78254910.1155/2013/782549 ↗
2. 10.1023/B:ABME.0000017544.36001.8e10.1023/B:ABME.0000017544.36001.8e ↗
3. 10.3389/fbioe.2020.0047410.3389/fbioe.2020.00474 ↗
4. 10.1016/j.stomax.2011.06.00310.1016/j.stomax.2011.06.003 ↗
5. 10.1563/1548-1336-35.1.2810.1563/1548-1336-35.1.28 ↗
6. 10.3928/0147-7447-20021101-2710.3928/0147-7447-20021101-27 ↗
7. 10.1186/s40824-019-0157-y10.1186/s40824-019-0157-y ↗
8. 10.1177/204173141877681910.1177/2041731418776819 ↗
9. 10.1097/00003086-200101000-0000810.1097/00003086-200101000-00008 ↗
10. 10.1097/01.ta.0000240452.64138.b010.1097/01.ta.0000240452.64138.b0 ↗
11. 10.1097/MD.000000000000363110.1097/MD.0000000000003631 ↗
12. 10.1016/j.actbio.2015.09.00510.1016/j.actbio.2015.09.005 ↗
13. 10.1002/adfm.20170059110.1002/adfm.201700591 ↗
14. 10.1073/pnas.111947410910.1073/pnas.1119474109 ↗
15. 10.1016/j.jconrel.2015.07.03110.1016/j.jconrel.2015.07.031 ↗
16. 10.1039/C7RA03288A10.1039/C7RA03288A ↗
17. 10.1038/s41598-018-25643-x10.1038/s41598-018-25643-x ↗
18. 10.1002/btm2.1022110.1002/btm2.10221 ↗
19. Ramakrishna S. · Med. Devices · 2015 · 13710.1016/B978-0-08-100289-6.00006-5 ↗
20. https://www.iso.org/standard/68936.html.
21. Nisal, A.; Venugopalan, P.; Khude, B. CSIR-National Chemical Laboratory. WO2016110873A12016, 1 9.
22. Nisal, A.; Venugopalan, P.; Sinha, N. CSIR-National Chemical Laboratory. WO2014125505A12014, 1 10.
23. 10.1159/00013107710.1159/000131077 ↗
24. 10.1155/2015/13728710.1155/2015/137287 ↗
25. 10.1016/j.biomaterials.2004.02.04710.1016/j.biomaterials.2004.02.047 ↗
26. 10.1242/dev.13925310.1242/dev.139253 ↗
27. 10.1097/00001665-200011040-0000910.1097/00001665-200011040-00009 ↗
28. 10.1563/aaid-joi-D-19-0020110.1563/aaid-joi-D-19-00201 ↗
29. 10.1016/j.biomaterials.2015.08.03910.1016/j.biomaterials.2015.08.039 ↗
30. 10.1097/BLO.0b013e318059b90210.1097/BLO.0b013e318059b902 ↗
31. 10.1016/j.actbio.2016.03.03310.1016/j.actbio.2016.03.033 ↗
32. 10.1177/002203451877803310.1177/0022034518778033 ↗
33. 10.1007/s11914-017-0402-z10.1007/s11914-017-0402-z ↗
34. 10.1177/002203451037779110.1177/0022034510377791 ↗
35. 10.1007/s11914-014-0213-410.1007/s11914-014-0213-4 ↗
36. 10.1007/s10867-008-9115-y10.1007/s10867-008-9115-y ↗
37. 10.3389/fphar.2020.0075710.3389/fphar.2020.00757 ↗
38. 10.1242/dev.13925310.1242/dev.139253 ↗
39. 10.1007/s10856-020-06483-610.1007/s10856-020-06483-6 ↗
40. 10.1002/jbm.a.3582810.1002/jbm.a.35828 ↗
41. 10.1097/BOT.000000000000111510.1097/BOT.0000000000001115 ↗